China Pharma Holdings Inc. (CPHI)
CPHI trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.7514
-13.53% on the day
Market cap
$32.3M
Nano cap
Revenue · 2025
$4.1M
-8.5% on 2024
Net income · 2025
-$3.2M
-76.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CPHI on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | China |
| IPO year | Not reported by the screener |
| SEC CIK | 0001106644 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $4.1M |
| Net income | -$3.2M |
| Operating income | -$3.2M |
| Net margin | -76.9% |
| Operating margin | -78.2% |
| Revenue growth | -8.5% |
| Cash | $345K |
| Total assets | $31.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 7.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-07-23 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-04-01 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-07-22 |
| Latest proxy DEFINITIVE PROXY STATEMENT | DEF 14A | 2025-11-14 |
Source: SEC EDGAR submissions feed, 425 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BCTX | BriaCell Therapeutics Corp. Common Shares | $3.71 | -4.13% | $32.3M |
| GRDX | GridAI Technologies Corp. | $4.55 | -2.36% | $32.4M |
| JAGX | Jaguar Health Inc. | $4.16 | -10.35% | $32.5M |
| RMTI | Rockwell Medical Inc. | $7.85 | +3.70% | $31.6M |
| ATNM | Actinium Pharmaceuticals Inc. (Delaware) | $0.9995 | -5.71% | $31.4M |
| NNVC | NanoViricides Inc. | $1.32 | +3.13% | $33.7M |
| IBO | Impact BioMedical Inc. | $3.98 | -1.24% | $34.0M |
| CRVO | CervoMed Inc. | $2.27 | -9.56% | $34.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier